These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 30928169)

  • 81. Low-grade lymphoma.
    Winter JN; Gascoyne RD; Van Besien K
    Hematology Am Soc Hematol Educ Program; 2004; ():203-20. PubMed ID: 15561684
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Rituximab therapy for follicular lymphoma: a comprehensive review of its efficacy as primary treatment, treatment for relapsed disease, re-treatment and maintenance.
    Cohen Y; Solal-Céligny P; Polliack A
    Haematologica; 2003 Jul; 88(7):811-23. PubMed ID: 12857561
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Impact of prior treatment on outcome of transformed follicular lymphoma and relapsed de novo diffuse large B cell lymphoma: a retrospective multicentre analysis.
    Lerch K; Meyer AH; Stroux A; Hirt C; Keller U; Viardot A; Marks R; Schreiber S; Pezzutto A; Scholz CW
    Ann Hematol; 2015 Jun; 94(6):981-8. PubMed ID: 25645656
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Copanlisib in the Treatment of Relapsed Follicular Lymphoma: Utility and Experience from the Clinic.
    Chauhan AF; Cheson BD
    Cancer Manag Res; 2021; 13():677-692. PubMed ID: 33531838
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Extrafollicular PD1 and Intrafollicular CD3 Expression Are Associated With Survival in Follicular Lymphoma.
    Meirav K; Ginette S; Tamar T; Iris B; Arnon N; Abraham A
    Clin Lymphoma Myeloma Leuk; 2017 Oct; 17(10):645-649. PubMed ID: 28733197
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Autologous Stem Cell Transplantation for Patients with Early Progression of Follicular Lymphoma: A Follow-Up Study of 2 Randomized Trials from the German Low Grade Lymphoma Study Group.
    Jurinovic V; Metzner B; Pfreundschuh M; Schmitz N; Wandt H; Keller U; Dreger P; Dreyling M; Hiddemann W; Unterhalt M; Hoster E; Weigert O
    Biol Blood Marrow Transplant; 2018 Jun; 24(6):1172-1179. PubMed ID: 29605716
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Population-based analysis of incidence and outcome of transformed non-Hodgkin's lymphoma.
    Al-Tourah AJ; Gill KK; Chhanabhai M; Hoskins PJ; Klasa RJ; Savage KJ; Sehn LH; Shenkier TN; Gascoyne RD; Connors JM
    J Clin Oncol; 2008 Nov; 26(32):5165-9. PubMed ID: 18838711
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Clinical and molecular prognostic factors in follicular lymphoma.
    Davies AJ
    Curr Oncol Rep; 2006 Sep; 8(5):359-67. PubMed ID: 16901397
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Treatment strategies in advanced stage follicular lymphoma.
    van Oers MH; Kersten MJ
    Best Pract Res Clin Haematol; 2011 Jun; 24(2):187-201. PubMed ID: 21658618
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Hematopoietic cell transplantation for diffuse large B-cell and follicular lymphoma: Current controversies and advances.
    Epperla N; Hamadani M
    Hematol Oncol Stem Cell Ther; 2017 Dec; 10(4):277-284. PubMed ID: 28633038
    [TBL] [Abstract][Full Text] [Related]  

  • 91. The routes for transformation of follicular lymphoma.
    Okosun J; Montoto S; Fitzgibbon J
    Curr Opin Hematol; 2016 Jul; 23(4):385-91. PubMed ID: 27135979
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Ocular adnexal follicular lymphoma: a multicenter international study.
    Rasmussen PK; Coupland SE; Finger PT; Graue GF; Grossniklaus HE; Honavar SG; McKelvie P; Mulay K; Prause JU; Ralfkiaer E; Sjö LD; Heegaard S
    JAMA Ophthalmol; 2014 Jul; 132(7):851-8. PubMed ID: 24763920
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Surrogate Endpoints and Risk Adaptive Strategies in Previously Untreated Follicular Lymphoma.
    Narkhede MS; Cheson BD
    Clin Lymphoma Myeloma Leuk; 2018 Jul; 18(7):447-451. PubMed ID: 29773430
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Gene expression profiling in follicular lymphoma to assess clinical aggressiveness and to guide the choice of treatment.
    Glas AM; Kersten MJ; Delahaye LJ; Witteveen AT; Kibbelaar RE; Velds A; Wessels LF; Joosten P; Kerkhoven RM; Bernards R; van Krieken JH; Kluin PM; van't Veer LJ; de Jong D
    Blood; 2005 Jan; 105(1):301-7. PubMed ID: 15345589
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Risk stratification in follicular lymphoma.
    Casulo C
    Best Pract Res Clin Haematol; 2018 Mar; 31(1):15-22. PubMed ID: 29452661
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Convergence of risk prediction models in follicular lymphoma.
    Silva A; Bassim S; Sarkozy C; Mottok A; Lackraj T; Jurinovic V; Brodtkorb M; Lingjaerde OC; Sehn LH; Gascoyne RD; Weigert O; Steidl C; Kridel R
    Haematologica; 2019 Jun; 104(6):e252-e255. PubMed ID: 30606786
    [No Abstract]   [Full Text] [Related]  

  • 97. Toward a Cure for Follicular Lymphoma.
    Friedberg JW
    Hematol Oncol Clin North Am; 2020 Aug; 34(4):xiii-xiv. PubMed ID: 32586582
    [No Abstract]   [Full Text] [Related]  

  • 98. Upfront identification of high-risk follicular lymphoma.
    Casulo C
    Hematol Oncol; 2021 Jun; 39 Suppl 1():88-93. PubMed ID: 34105811
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Spotlight on copanlisib and its potential in the treatment of relapsed/refractory follicular lymphoma: evidence to date.
    Mensah FA; Blaize JP; Bryan LJ
    Onco Targets Ther; 2018; 11():4817-4827. PubMed ID: 30147333
    [TBL] [Abstract][Full Text] [Related]  

  • 100. ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of newly diagnosed follicular lymphoma.
    Hiddemann W;
    Ann Oncol; 2003 Aug; 14(8):1163-4. PubMed ID: 12881368
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.